HLTY - PreCheck Health Services, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3800
0.0000 (0.00%)
At close: 1:16PM EST
Stock chart is not supported by your current browser
Previous Close0.3800
Open0.3800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3800 - 0.3800
52 Week Range0.2103 - 1.3500
Volume900
Avg. Volume2,011
Market Cap5.9M
Beta (5Y Monthly)0.02
PE Ratio (TTM)N/A
EPS (TTM)-0.5810
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    PreCheck Health Services Signs Additional Binding Agreement to Acquire Companies to Strengthen Its Point-of-Care Medical Screening Capabilities

    PreCheck Health Services, Inc. (“PreCheck” or the “Company”) (HLTY), a provider of medical screening devices which provide data to assist physicians in preventing and treating chronic diseases, announced today that the Company has executed an additional binding agreement for the acquisition of two companies, in addition to the two companies which were previously announced.

  • GlobeNewswire

    PreCheck Health Services, Inc. Announces Strategic Acquisitions

    PreCheck Health Services, Inc. (“PreCheck” or the “Company”) (HLTY), a provider of medical screening devices which provide data to assist physicians in preventing and treating chronic diseases, announced today that the Company has entered into a purchase agreement with Justin and Stacey Anderson to acquire JAS Practice Management, Inc. dba JAS Consulting, Inc. and Center for Psychological Development, Inc., dba CPD Integrated Health Care.  Mr. Anderson is the Company’s chief operating officer and a director.

  • GlobeNewswire

    PreCheck Health Services, Inc. Closes $1,250,000 Bank Credit Facility

    PreCheck Health Services, Inc. (HLTY), announced that it entered into a $1,250,000 revolving credit facility with Oakwood Bank.  The Company intends to use the facility for working capital and other corporate purposes, including the launch of its marketing effort for its PC8B medical screening device for use by physicians and medical personnel. The line of credit is secured by the Company’s assets and is guaranteed by two minority stockholders. PreCheck Health Services Inc. is a Florida corporation which distributes the PC8B, a medical screening device.  The PC8B medical device is a powerful screening tool in managing patients' health.

  • GlobeNewswire

    PreCheck Health Services, Inc. appoints Dr. Mitch Ghen as its Chief Science Officer

    PreCheck Health Services, Inc. (HLTY), announced that it has appointed Dr. Mitch Ghen as its chief science officer.   As chief science officer, Dr. Ghen will respond to queries regarding clinical or technical issues relating to our product, assist in the evaluation on new products and help us in our training and marketing programs. Dr. Ghen will work for us on a part-time basis. In addition to being a physician, with a private practice in Boca Raton, Florida, Dr. Ghen holds a master’s degree in biomechanical trauma and has a Ph.D. in nutrition and psychoneuroimmunology.

  • GlobeNewswire

    PreCheck Health Services, Inc. to present at the 5th annual MedTech Monday conference

    PreCheck Health Services, Inc. (HLTY), will be presenting at MedTech Monday in Costa Mesa California at the Avenue of the Arts next week on Monday the 28th of January. This is the 5th annual MedTech Monday conference that provides Orange County with the latest medical device innovations, investment insights, biotech advancements, startups and discussions with industry leaders on the direction of the industry here in 2019 and beyond. “We are excited to be presenting at this conference with many of the new innovative medical device companies in the market today.

  • GlobeNewswire

    PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device

    PreCheck Health Services, Inc. (HLTY) is a Florida corporation that has entered into an exclusive distribution agreement for the new PreCheck Health Services “PC8B” medical device for sale coast to coast in the United States. The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies.